ATE102188T1 - Benzazepinderivate. - Google Patents
Benzazepinderivate.Info
- Publication number
- ATE102188T1 ATE102188T1 AT89110490T AT89110490T ATE102188T1 AT E102188 T1 ATE102188 T1 AT E102188T1 AT 89110490 T AT89110490 T AT 89110490T AT 89110490 T AT89110490 T AT 89110490T AT E102188 T1 ATE102188 T1 AT E102188T1
- Authority
- AT
- Austria
- Prior art keywords
- bridge
- alkyl
- halogen
- hydrogen
- benzazepine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK325188A DK325188D0 (da) | 1988-06-15 | 1988-06-15 | Hidtil ukendte benzazepinderivater |
EP89110490A EP0347672B1 (de) | 1988-06-15 | 1989-06-09 | Benzazepinderivate |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE102188T1 true ATE102188T1 (de) | 1994-03-15 |
Family
ID=8120790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT89110490T ATE102188T1 (de) | 1988-06-15 | 1989-06-09 | Benzazepinderivate. |
Country Status (15)
Country | Link |
---|---|
US (2) | US5010074A (de) |
EP (1) | EP0347672B1 (de) |
JP (1) | JP2769718B2 (de) |
AT (1) | ATE102188T1 (de) |
AU (1) | AU622911B2 (de) |
CA (1) | CA1317938C (de) |
DE (1) | DE68913367T2 (de) |
DK (1) | DK325188D0 (de) |
ES (1) | ES2061794T3 (de) |
FI (1) | FI93354C (de) |
IE (1) | IE891932L (de) |
IL (1) | IL90533A (de) |
NO (1) | NO173865C (de) |
NZ (1) | NZ229521A (de) |
PT (1) | PT90883B (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK67489D0 (da) * | 1989-02-14 | 1989-02-14 | Novo Industri As | Nye benzazepinderivater |
US5158948A (en) * | 1990-11-16 | 1992-10-27 | Abbott Laboratories | Tetracyclic spirobenzazepine dopamine antagonists |
US5470850A (en) * | 1992-02-24 | 1995-11-28 | Novo Nordisk A/S | 2,3,4,5-tetrahydro-1H-3-benzazepines |
DK23392D0 (da) * | 1992-02-24 | 1992-02-24 | Novo Nordisk As | Heterocykliske forbindelser, deres anvendelse og fremstilling |
CA2283083C (en) | 1997-03-12 | 2007-09-04 | Novo Nordisk A/S | Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders |
US6277844B1 (en) | 1998-09-14 | 2001-08-21 | Sydney Spector | Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis |
GB0130576D0 (en) * | 2001-12-20 | 2002-02-06 | Cenes Ltd | Dopamine D1 receptor agonist pro-drug compounds & derivatives |
US7211574B2 (en) * | 2002-08-29 | 2007-05-01 | Schering Corporation | Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders |
US7696193B2 (en) | 2002-12-20 | 2010-04-13 | Glaxo Group Limited | Benzazepine derivatives for the treatment of neurological disorders |
CA2526017A1 (en) * | 2003-05-22 | 2005-04-21 | Schering Corporation | 5-h-benzo[d]naphth[2,1-b]azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1268243A (en) * | 1968-03-11 | 1972-03-22 | Wallace & Tiernan Inc | 0,2,4,5,-tetrahydro-3h,3-benzazepines |
US4210749A (en) * | 1974-11-12 | 1980-07-01 | Pennwalt Corporation | Substituted 1,2,4,5-tetrahydro-3H,3 benzazepines |
ZA792042B (en) * | 1978-05-08 | 1980-05-28 | Scherico Ltd | Substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof and pharmaceutical compositions containing them |
US4327023A (en) * | 1980-01-31 | 1982-04-27 | Smithkline Corporation | Intermediates for preparing 7,8-amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines |
US4284556A (en) * | 1980-01-31 | 1981-08-18 | Smithkline Corporation | 7,8-Amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines |
DK180485D0 (da) * | 1985-04-22 | 1985-04-23 | Novo Industri As | Nitrogenholdige forbindelser |
JPH0681745B2 (ja) * | 1986-01-16 | 1994-10-19 | シェリング・コ−ポレ−ション | 縮合ベンゾアゼピン |
EP0244088A3 (de) * | 1986-04-03 | 1989-03-15 | Smithkline Beecham Corporation | 1-Phenyl-3-benzazepin-Verbindungen und diese enthaltende Arzneimittel zur Behandlung von Störungen des gastrointestinalen Bewegungsvermögens |
-
1988
- 1988-06-15 DK DK325188A patent/DK325188D0/da not_active Application Discontinuation
-
1989
- 1989-06-05 IL IL9053389A patent/IL90533A/en unknown
- 1989-06-09 AT AT89110490T patent/ATE102188T1/de not_active IP Right Cessation
- 1989-06-09 EP EP89110490A patent/EP0347672B1/de not_active Expired - Lifetime
- 1989-06-09 DE DE68913367T patent/DE68913367T2/de not_active Expired - Lifetime
- 1989-06-09 ES ES89110490T patent/ES2061794T3/es not_active Expired - Lifetime
- 1989-06-12 US US07/365,250 patent/US5010074A/en not_active Expired - Lifetime
- 1989-06-13 CA CA000602684A patent/CA1317938C/en not_active Expired - Lifetime
- 1989-06-13 NZ NZ229521A patent/NZ229521A/en unknown
- 1989-06-14 NO NO892476A patent/NO173865C/no not_active IP Right Cessation
- 1989-06-14 AU AU36359/89A patent/AU622911B2/en not_active Expired
- 1989-06-15 IE IE891932A patent/IE891932L/xx not_active IP Right Cessation
- 1989-06-15 PT PT90883A patent/PT90883B/pt not_active IP Right Cessation
- 1989-06-15 JP JP1150662A patent/JP2769718B2/ja not_active Expired - Lifetime
- 1989-06-15 FI FI892946A patent/FI93354C/fi active IP Right Grant
-
1990
- 1990-02-07 US US07/477,450 patent/US5025009A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
IL90533A (en) | 1994-05-30 |
ES2061794T3 (es) | 1994-12-16 |
NO173865C (no) | 1994-02-16 |
IE891932L (en) | 1989-12-15 |
FI892946A (fi) | 1989-12-16 |
FI93354C (fi) | 1995-03-27 |
FI892946A0 (fi) | 1989-06-15 |
NZ229521A (en) | 1991-12-23 |
EP0347672A1 (de) | 1989-12-27 |
JPH0240364A (ja) | 1990-02-09 |
DE68913367T2 (de) | 1994-06-01 |
FI93354B (fi) | 1994-12-15 |
CA1317938C (en) | 1993-05-18 |
NO892476D0 (no) | 1989-06-14 |
PT90883B (pt) | 1994-12-30 |
NO892476L (no) | 1989-12-18 |
US5010074A (en) | 1991-04-23 |
US5025009A (en) | 1991-06-18 |
JP2769718B2 (ja) | 1998-06-25 |
DE68913367D1 (de) | 1994-04-07 |
NO173865B (no) | 1993-11-08 |
IL90533A0 (en) | 1990-01-18 |
AU3635989A (en) | 1989-12-21 |
EP0347672B1 (de) | 1994-03-02 |
AU622911B2 (en) | 1992-04-30 |
PT90883A (pt) | 1989-12-29 |
DK325188D0 (da) | 1988-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5752194A (en) | Benzimidazole compounds, their use and preparation | |
ATE263771T1 (de) | Totalsynthese von acylfulvenen mit antitumorwirkung | |
ATE102188T1 (de) | Benzazepinderivate. | |
DE69505470D1 (de) | Pyrrolocarbazol | |
GB8828669D0 (en) | Organic compounds | |
EP0285284A3 (en) | N-phenethylaminoalkyl-benzamide anti-arrhythmia agents | |
NO173991C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater | |
NO894384L (no) | Forbindelser for behandling av urininkontinens. | |
DE69827706D1 (de) | 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems | |
ATE56432T1 (de) | Substituierte 1,3,4,9-tetrahydropyrano(3,4b>indole-1-essigs|ure. | |
DK294389A (da) | Nye benzazepin derivater | |
PH24971A (en) | N2-thiocylcarbazate compounds and derivatives thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEIH | Change in the person of patent owner | ||
EELA | Cancelled due to lapse of time |